Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

Atbasoglu E. C., GÜMÜŞ AKAY G., Guloksuz S., SAKA M. C., Ucok A., ALPTEKİN K., ...More

PSYCHOPHARMACOLOGY, vol.235, no.4, pp.1029-1039, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 235 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.1007/s00213-017-4818-z
  • Journal Name: PSYCHOPHARMACOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1029-1039
  • Keywords: Dopamine, Genetics, Insulin resistance, Schizophrenia, Schizotypy, Type 2 diabetes mellitus, DRUG-NAIVE PATIENTS, 1ST-EPISODE SCHIZOPHRENIA, NEUROTROPHIC FACTOR, INSULIN-RESISTANCE, GLUCOSE-TOLERANCE, DIABETES-MELLITUS, PSYCHOSIS, ASSOCIATION, HOMEOSTASIS, PREVALENCE
  • Ankara University Affiliated: Yes

Abstract

Type 2 diabetes (T2D) is more frequent in schizophrenia (Sz) than in the general population. This association is partly accounted for by shared susceptibility genetic variants.